Net Cash Provided by (Used in) Financing Activities in USD of PRESSURE BIOSCIENCES INC from 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
PRESSURE BIOSCIENCES INC quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2024.
  • PRESSURE BIOSCIENCES INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $1,781,501, a 170% increase year-over-year.
  • PRESSURE BIOSCIENCES INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3,270,919, a 25% decline from 2022.
  • PRESSURE BIOSCIENCES INC annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4,370,350, a 14% decline from 2021.
  • PRESSURE BIOSCIENCES INC annual Net Cash Provided by (Used in) Financing Activities for 2021 was $5,105,289, a 9.9% decline from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

PRESSURE BIOSCIENCES INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $1,781,501 +$1,121,132 +170% 01 Jan 2024 31 Mar 2024 10-Q 06 Sep 2024 2024 Q1
Q1 2023 $660,369 -$83,540 -11% 01 Jan 2023 31 Mar 2023 10-Q 06 Sep 2024 2024 Q1
Q1 2022 $743,909 -$529,058 -42% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $1,272,967 -$93,866 -6.9% 01 Jan 2021 31 Mar 2021 10-Q 19 May 2022 2022 Q1
Q1 2020 $1,366,833 -$430,302 -24% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q1 2019 $1,797,135 +$519,494 +41% 01 Jan 2019 31 Mar 2019 10-Q 29 Jun 2020 2020 Q1
Q1 2018 $1,277,641 +$113,548 +9.8% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q1 2017 $1,164,093 -$45,969 -3.8% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q1 2016 $1,210,062 +$413,218 +52% 01 Jan 2016 31 Mar 2016 10-Q 16 May 2017 2017 Q1
Q1 2015 $796,844 -$709,288 -47% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q1 2014 $1,506,132 +$720,655 +92% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q1 2013 $785,477 +$408,023 +108% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q1 2012 $377,454 +$333,474 +758% 01 Jan 2012 31 Mar 2012 10-Q 20 May 2013 2013 Q1
Q1 2011 $43,980 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q1

PRESSURE BIOSCIENCES INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $3,270,919 -$1,099,431 -25% 01 Jan 2023 31 Dec 2023 10-K 07 Jun 2024 2023 FY
2022 $4,370,350 -$734,939 -14% 01 Jan 2022 31 Dec 2022 10-K 07 Jun 2024 2023 FY
2021 $5,105,289 -$563,483 -9.9% 01 Jan 2021 31 Dec 2021 10-K 12 Apr 2023 2022 FY
2020 $5,668,772 -$608,688 -9.7% 01 Jan 2020 31 Dec 2020 10-K 05 Apr 2022 2021 FY
2019 $6,277,460 +$559,471 +9.8% 01 Jan 2019 31 Dec 2019 10-K 15 Apr 2021 2020 FY
2018 $5,717,989 +$1,698,945 +42% 01 Jan 2018 31 Dec 2018 10-K 14 Apr 2020 2019 FY
2017 $4,019,044 +$184,410 +4.8% 01 Jan 2017 31 Dec 2017 10-K 16 Apr 2019 2018 FY
2016 $3,834,634 +$362,641 +10% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $3,471,993 -$188,255 -5.1% 01 Jan 2015 31 Dec 2015 10-K 22 Mar 2017 2016 FY
2014 $3,660,248 +$1,228,940 +51% 01 Jan 2014 31 Dec 2014 10-K 05 Apr 2016 2015 FY
2013 $2,431,308 +$487,821 +25% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
2012 $1,943,487 +$129,056 +7.1% 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014 2013 FY
2011 $1,814,431 -$92,931 -4.9% 01 Jan 2011 31 Dec 2011 10-K 13 May 2013 2012 FY
2010 $1,907,362 01 Jan 2010 31 Dec 2010 10-K 27 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.